Brain Scientific Inc.
Brain Scientific Inc.
Your view on BRSF
Overview
What the company does, where it operates, and who runs it.
About Brain Scientific Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Hassan Kotob
- Headquarters
- 6700 Professional Parkway, Sarasota, FL, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Hassan Kotob
- Headquarters
- 6700 Professional Parkway, Sarasota, FL, US
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. The company also develops motor platforms; an ultra-precise micro dosing pump; and motion products.
The company offers NeuroCap, a disposable and soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional EEG systems; and NeuroEEG, a clinical-grade device for prescription use to acquire, record, transmit, and display electrical brain activity for patients of all ages, as well as NeuroNet Cloud, a database where brain data can be stored and analyzed. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Brain Scientific Inc., and the rating behind it. BRSF last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Brain Scientific Inc.. Starting points for Brain Scientific Inc.: EPS -$12.95, beta 0.73 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Brain Scientific Inc.. Brain Scientific Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Brain Scientific Inc.. Trailing twelve-month EPS for Brain Scientific Inc. stands at -$12.95. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Brain Scientific Inc.. Brain Scientific Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Brain Scientific Inc. valued side by side against its closest peers. Brain Scientific Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Brain Scientific Inc., and how their positions are changing. At a $124 market value, institutional positions materially move Brain Scientific Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Brain Scientific Inc. executives and directors. Shares of Brain Scientific Inc. have traded between $0.0001 and $0.75 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Brain Scientific Inc.. Brain Scientific Inc. is a $124 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Brain Scientific Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Brain Scientific Inc.. Coverage tracks Brain Scientific Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.